GB0723712D0 - Peptides - Google Patents

Peptides

Info

Publication number
GB0723712D0
GB0723712D0 GBGB0723712.6A GB0723712A GB0723712D0 GB 0723712 D0 GB0723712 D0 GB 0723712D0 GB 0723712 A GB0723712 A GB 0723712A GB 0723712 D0 GB0723712 D0 GB 0723712D0
Authority
GB
United Kingdom
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0723712.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apitope Technology Bristol Ltd
Original Assignee
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Ltd filed Critical Apitope Technology Bristol Ltd
Priority to GBGB0723712.6A priority Critical patent/GB0723712D0/en
Publication of GB0723712D0 publication Critical patent/GB0723712D0/en
Priority to UAA201008194A priority patent/UA101003C2/uk
Priority to ES08855772.3T priority patent/ES2458315T7/es
Priority to CA3005013A priority patent/CA3005013C/en
Priority to US12/746,141 priority patent/US8445448B2/en
Priority to SI200831186T priority patent/SI2227488T1/sl
Priority to AU2008332968A priority patent/AU2008332968B2/en
Priority to MX2010006084A priority patent/MX2010006084A/es
Priority to BRPI0820143 priority patent/BRPI0820143A2/pt
Priority to JP2010536523A priority patent/JP5501245B2/ja
Priority to EA201070681A priority patent/EA019370B1/ru
Priority to KR1020107011743A priority patent/KR101519840B1/ko
Priority to CN200880119313.1A priority patent/CN101889024B/zh
Priority to DK08855772.3T priority patent/DK2227488T6/en
Priority to PL08855772T priority patent/PL2227488T6/pl
Priority to MYPI20102567 priority patent/MY150995A/en
Priority to NZ585217A priority patent/NZ585217A/xx
Priority to CA2707559A priority patent/CA2707559C/en
Priority to CN201310392152.6A priority patent/CN103709234B/zh
Priority to EP08855772.3A priority patent/EP2227488B3/en
Priority to HRP20140344TT priority patent/HRP20140344T4/hr
Priority to PCT/GB2008/003996 priority patent/WO2009071886A1/en
Priority to HK10110866.8A priority patent/HK1144292B/en
Priority to PT88557723T priority patent/PT2227488E/pt
Priority to ZA2010/02997A priority patent/ZA201002997B/en
Priority to IL205780A priority patent/IL205780A/en
Priority to EC2010010327A priority patent/ECSP10010327A/es
Priority to JP2014023217A priority patent/JP6063402B2/ja
Priority to CY20141100281T priority patent/CY1115168T1/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0723712.6A 2007-12-04 2007-12-04 Peptides Ceased GB0723712D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
UAA201008194A UA101003C2 (uk) 2007-12-04 2008-03-12 Пептид фактора fviii та його застосування для індукції толерантності у хворих гемофілією
PT88557723T PT2227488E (pt) 2007-12-04 2008-12-03 Péptidos fviii e seu uso na tolerização de hemofílicos
PL08855772T PL2227488T6 (pl) 2007-12-04 2008-12-03 FVIII Peptydy i ich zastosowanie w indukcji tolerancji u chorych na hemofilię
MYPI20102567 MY150995A (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
US12/746,141 US8445448B2 (en) 2007-12-04 2008-12-03 FVIII peptides and their use in tolerising haemophiliacs
SI200831186T SI2227488T1 (sl) 2007-12-04 2008-12-03 FVIII peptidi in njihova uporaba pri toleriziranju hemofilikov
AU2008332968A AU2008332968B2 (en) 2007-12-04 2008-12-03 FVIII peptides and their use in tolerising haemophiliacs
MX2010006084A MX2010006084A (es) 2007-12-04 2008-12-03 Peptidos del factor viii y su uso en la tolerizacion de hemofilicos.
BRPI0820143 BRPI0820143A2 (pt) 2007-12-04 2008-12-03 Peptideos de fviii e seu uso em tolerização de hemofílicos
JP2010536523A JP5501245B2 (ja) 2007-12-04 2008-12-03 Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用
EA201070681A EA019370B1 (ru) 2007-12-04 2008-12-03 Пептиды fviii и их применение для индукции толерантности у больных гемофилией
KR1020107011743A KR101519840B1 (ko) 2007-12-04 2008-12-03 Ｆⅷ 펩타이드 및 혈우병 환자 내성화시 그의 용도
CN200880119313.1A CN101889024B (zh) 2007-12-04 2008-12-03 Fviii肽和它们用于耐受化血友病患者的用途
DK08855772.3T DK2227488T6 (en) 2007-12-04 2008-12-03 FVIII PEPTIDES AND THEIR USE for inducing tolerance in hemophilic
ES08855772.3T ES2458315T7 (es) 2007-12-04 2008-12-03 Péptidos de FVIII y su uso en la inducción de tolerancia en pacientes hemofílicos
CA3005013A CA3005013C (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
NZ585217A NZ585217A (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
CA2707559A CA2707559C (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
CN201310392152.6A CN103709234B (zh) 2007-12-04 2008-12-03 Fviii 肽和它们用于耐受化血友病患者的用途
EP08855772.3A EP2227488B3 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
HRP20140344TT HRP20140344T4 (hr) 2007-12-04 2008-12-03 Fviii peptidi i njihova uporaba u lijeäśenju hemofilije
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
HK10110866.8A HK1144292B (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs
ZA2010/02997A ZA201002997B (en) 2007-12-04 2010-04-29 Fvii peptides and their use in tolerising haemophiliacs
IL205780A IL205780A (en) 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii
EC2010010327A ECSP10010327A (es) 2007-12-04 2010-07-02 Péptidos del fviii y su uso para hemofílicos tolerantes
JP2014023217A JP6063402B2 (ja) 2007-12-04 2014-02-10 Ｆｖｉｉｉペプチドおよび血友病を寛容化することにおけるその使用
CY20141100281T CY1115168T1 (el) 2007-12-04 2014-04-15 Πεπτιδια fviii και η χρηση τους στην επαγωγη ανοχης των αιμορροφιλικων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides

Publications (1)

Publication Number Publication Date
GB0723712D0 true GB0723712D0 (en) 2008-01-16

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0723712.6A Ceased GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides

Country Status (25)

Country Link
US (1) US8445448B2 (cg-RX-API-DMAC7.html)
EP (1) EP2227488B3 (cg-RX-API-DMAC7.html)
JP (2) JP5501245B2 (cg-RX-API-DMAC7.html)
KR (1) KR101519840B1 (cg-RX-API-DMAC7.html)
CN (2) CN103709234B (cg-RX-API-DMAC7.html)
AU (1) AU2008332968B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820143A2 (cg-RX-API-DMAC7.html)
CA (2) CA2707559C (cg-RX-API-DMAC7.html)
CY (1) CY1115168T1 (cg-RX-API-DMAC7.html)
DK (1) DK2227488T6 (cg-RX-API-DMAC7.html)
EA (1) EA019370B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP10010327A (cg-RX-API-DMAC7.html)
ES (1) ES2458315T7 (cg-RX-API-DMAC7.html)
GB (1) GB0723712D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20140344T4 (cg-RX-API-DMAC7.html)
IL (1) IL205780A (cg-RX-API-DMAC7.html)
MX (1) MX2010006084A (cg-RX-API-DMAC7.html)
MY (1) MY150995A (cg-RX-API-DMAC7.html)
NZ (1) NZ585217A (cg-RX-API-DMAC7.html)
PL (1) PL2227488T6 (cg-RX-API-DMAC7.html)
PT (1) PT2227488E (cg-RX-API-DMAC7.html)
SI (1) SI2227488T1 (cg-RX-API-DMAC7.html)
UA (1) UA101003C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009071886A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201002997B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353347T3 (es) 2000-08-21 2011-03-01 Apitope Technology (Bristol) Limited Péptido.
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
SI2300497T1 (sl) * 2008-06-24 2013-02-28 Octapharma Ag Postopek za äťiĺˇäťenje koagulacijskega faktorja viii
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2765657A1 (en) * 2009-06-16 2010-12-23 Tokai University Anti-gram-negative bacteria agent
CN104926947A (zh) 2010-10-27 2015-09-23 巴克斯特国际公司 用于免疫耐受性诱导和免疫诊断的fviii肽
CA2863329C (en) 2012-01-12 2023-01-03 Biogen Idec Ma Inc. Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii therapy
EA036483B1 (ru) * 2012-11-12 2020-11-16 Эпитоп Интернэшнл Нв Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
CA3007262A1 (en) 2015-12-03 2017-06-08 Lucas James Thompson Modified chimeric receptors and related compositions and methods
KR20190091292A (ko) 2016-12-02 2019-08-05 바이오버라티브 테라퓨틱스 인크. 응고 인자에 대한 면역 내성 유도 방법
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5930890A (en) * 1989-06-20 1991-01-08 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
ES2353347T3 (es) * 2000-08-21 2011-03-01 Apitope Technology (Bristol) Limited Péptido.
WO2002060917A2 (en) * 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
HUP0303171A2 (hu) * 2001-02-19 2003-12-29 Merck Patent Gmbh Csökkentett immunogenitású mesterséges fehérjék
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
AU2003232482A1 (en) * 2002-04-18 2003-10-27 Merck Patent Gmbh Modified factor viii
AU2005211725B2 (en) * 2004-02-09 2010-07-15 Human Genome Sciences, Inc. Albumin fusion proteins
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
BRPI0820143A2 (pt) 2015-05-12
ES2458315T7 (es) 2015-02-18
NZ585217A (en) 2012-11-30
PT2227488E (pt) 2014-04-21
US20100323966A1 (en) 2010-12-23
SI2227488T1 (sl) 2014-06-30
MX2010006084A (es) 2010-06-23
AU2008332968A1 (en) 2009-06-11
EP2227488B3 (en) 2014-11-19
CY1115168T1 (el) 2016-12-14
ECSP10010327A (es) 2010-09-30
IL205780A0 (en) 2010-11-30
CN101889024A (zh) 2010-11-17
EA019370B1 (ru) 2014-03-31
CN103709234A (zh) 2014-04-09
PL2227488T3 (pl) 2014-07-31
DK2227488T6 (en) 2015-02-16
EP2227488B1 (en) 2014-01-22
IL205780A (en) 2015-06-30
CA3005013A1 (en) 2009-06-11
KR101519840B1 (ko) 2015-05-18
EA201070681A1 (ru) 2010-10-29
HK1144292A1 (en) 2011-02-11
HRP20140344T4 (hr) 2015-07-31
AU2008332968B2 (en) 2014-03-20
UA101003C2 (uk) 2013-02-25
ES2458315T3 (es) 2014-04-30
CA2707559C (en) 2018-07-03
DK2227488T3 (da) 2014-04-22
CN101889024B (zh) 2014-04-23
JP5501245B2 (ja) 2014-05-21
US8445448B2 (en) 2013-05-21
ZA201002997B (en) 2011-07-27
JP2011505414A (ja) 2011-02-24
HRP20140344T1 (en) 2014-05-09
MY150995A (en) 2014-03-31
PL2227488T6 (pl) 2015-04-30
CN103709234B (zh) 2017-01-18
WO2009071886A1 (en) 2009-06-11
CA2707559A1 (en) 2009-06-11
KR20100087346A (ko) 2010-08-04
JP6063402B2 (ja) 2017-01-18
EP2227488A1 (en) 2010-09-15
JP2014088440A (ja) 2014-05-15
CA3005013C (en) 2021-11-16

Similar Documents

Publication Publication Date Title
HUE046149T2 (hu) Fehérje
GB0721686D0 (en) Polypeptides
GB0723712D0 (en) Peptides
EP2017283A4 (en) Peptides
ZA201000283B (en) Reinigung pegylierter polypeptide
IL202120A0 (en) Signaling peptides
ZA201001451B (en) Immunomodulatory peptides
PT2125871E (pt) Péptidos antibacterianos
GB0920981D0 (en) Peptides
EP2123666A4 (en) PEPTIDE
GB0719231D0 (en) Protein
GB0703945D0 (en) Peptide
EP2188305A4 (en) MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS
GB0712302D0 (en) Chrondroitinase polypeptides
EP2136831A4 (en) ANTI-ANGIOGENIC PEPTIDES
GB0809659D0 (en) Polypeptides
GB0618748D0 (en) Peptide
GB0920987D0 (en) Peptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0605774D0 (en) Peptide
GB0817978D0 (en) Peptides
GB0720563D0 (en) Protein
GB0705251D0 (en) Peptides
GB0705115D0 (en) Peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)